The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” ...
Pharmaceutical Technology on MSN17h
GSK and UK researchers plan to study Shingrix and dementia risk reduction linkThe study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback